Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

10836	Companies
235277	Keywords
164215	Articles
126032	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 05/02/2024 at 12:30, 2 years 3 months ago

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q1 revenues of $167 million, GAAP net loss of $1.2 billion, and diluted EPS of $(3.07). Company prepares for RSV vaccine and Spikevax® 2024-2025 formula launches, with expected product sales of $4 billion in 2024

Moderna Inc. Net Loss RSV Vaccine Q1 Revenues Spikevax 2024-2025 Formula
BRIEF

published on 04/25/2024 at 13:05, 2 years 3 months ago

Moderna to Present Diverse Research Studies at ESCMID Global Congress

COVID-19 Vaccine Moderna Vaccine Research Influenza Vaccine ESCMID Congress
PRESS RELEASE

published on 04/25/2024 at 13:00, 2 years 3 months ago

Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Moderna, Inc. to present data on COVID-19, influenza, respiratory syncytial virus, and cytomegalovirus vaccines at ESCMID Global Congress in Barcelona, Spain

COVID-19 Moderna Inc. Barcelona Vaccines ESCMID Global Congress
BRIEF

published on 04/24/2024 at 14:05, 2 years 3 months ago

Moderna Collaborates with OpenAI to Enhance mRNA Medicines Using Advanced AI

Healthcare Innovation MRNA Technology Moderna OpenAI AI Collaboration
PRESS RELEASE

published on 04/24/2024 at 14:00, 2 years 3 months ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine
Moderna and OpenAI collaborate to integrate generative AI tools, like ChatGPT Enterprise, into operations to enhance AI culture and augment employee roles for maximum impact on patients

Generative AI Machine Learning Moderna OpenAI ChatGPT Enterprise
BRIEF

published on 04/17/2024 at 13:05, 2 years 3 months ago

Moderna to Present Q1 2024 Financial Results in May

Financial Results Conference Call Webcast Moderna Q1 2024
PRESS RELEASE

published on 04/17/2024 at 13:00, 2 years 3 months ago

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Moderna, Inc. will host a live conference call to report Q1 2024 financial results and provide a corporate update. Moderna is a leader in mRNA medicine revolutionizing disease treatment

Financial Results Conference Call Corporate Update Moderna Inc. MRNA Medicine
BRIEF

published on 04/03/2024 at 17:05, 2 years 4 months ago

Moderna's mRNA Therapy for Propionic Acidemia Shows Promise in Early-Stage Trial

Gene Therapy Clinical Trial Moderna MRNA Therapy Propionic Acidemia
PRESS RELEASE

published on 04/03/2024 at 17:00, 2 years 4 months ago

Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Moderna, Inc. announced interim data for mRNA-3927 therapy for propionic acidemia published in Nature, showing signs of clinical benefit and safety. Ongoing global trial evaluates safety and efficacy in participants with PA

Clinical Trial Moderna Propionic Acidemia MRNA-3927 Genetic Disorder
BRIEF

published on 03/27/2024 at 11:35, 2 years 4 months ago

Moderna Announces Significant Advancements in Vaccine Development Programs

COVID-19 MRNA Technology Moderna Vaccine Development Phase 3 Clinical Trials

Accesswire

Published on 08/15/2026 at 00:50, 17 hours 28 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 18 hours 3 minutes ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 18 hours 33 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 18 hours 53 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 19 hours 18 minutes ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/15/2026 at 15:05, 3 hours 13 minutes ago

Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 10 hours 13 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 23 hours 49 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 1 day ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 1 day 2 hours ago

GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON

Les Echos

Published on 08/10/2026 at 18:00, 5 days ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 5 days ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 5 days 6 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 5 days 6 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 5 days 8 hours ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE